Latest Articles

Publication Date
Insights from focus groups with trans and gender-diverse people with endometriosis: stories you tell, stories you don't.

Endometriosis is a chronic condition characterised by cyclic pain symptoms that often significantly affect health-related quality of life. Predominantly framed as a "woman's condition," current research overlooks the experiences of …

Published: Sept. 17, 2025, midnight
SPP1 as a key modulator of M2 macrophage polarization promotes endometriosis progression via activation of the FAK/PI3K/AKT pathway: A bioinformatics and experimental study.

Endometriosis (EMs) is a gynecological disorder characterized by chronic inflammation and an aberrant immune microenvironment. In this study, we integrated the GSE6364 dataset from the GEO database to identify differentially …

Published: Sept. 17, 2025, midnight
The strategic role of lipidomics in biomarker identification and diagnosis of gynecological diseases.

Lipidomics, an emerging field in medical research, has deepened our understanding of lipid metabolism, signal transduction pathways, and intercellular communication through qualitative and quantitative analyses of patient lipid profiles. It …

Published: Sept. 17, 2025, midnight
What Our Health Care System Fails to Recognize About Women’s Pain - The Progressive

What Our Health Care System Fails to Recognize About Women’s Pain The Progressive

Published: Sept. 16, 2025, 9:42 p.m.
Lori Harvey reveals secret health battle that led to emergency surgery after a decade of 'excruciating' pain - Daily Mail

Lori Harvey reveals secret health battle that led to emergency surgery after a decade of 'excruciating' pain Daily Mail

Published: Sept. 16, 2025, 6:47 p.m.
Metformin Plus Letrozole and Abemaciclib Induces CRs in ER+ Recurrent Endometrial Cancer - OncLive

Metformin Plus Letrozole and Abemaciclib Induces CRs in ER+ Recurrent Endometrial Cancer OncLive

Published: Sept. 16, 2025, 2:01 p.m.
Trends in Endometriosis Management: A 10-Year US Claims Analysis.

To examine real-world treatment patterns for endometriosis and their alignment with clinical best-practice recommendations.

Published: Sept. 16, 2025, midnight
How long does combined hormonal therapy suppress AMH levels in women with endometriomas? Results from an exploratory analysis of a clinical trial.

Lower Anti-Müllerian hormone (AMH) levels have been observed in women with ovarian endometriomas (OMA) undergoing combined hormonal contraceptive (CHC) therapy. However, the extent and timing of AMH recovery after CHC …

Published: Sept. 16, 2025, midnight
Leveraging the role of the microbiome in endometriosis: novel non-invasive and therapeutic approaches.

Endometriosis (EMS) is an oestrogen-dependent condition characterised by ectopic endometrial-like tissue growth with a chronic and inflammatory nature leading to severe symptoms and reduced quality of life. Emerging evidence implicates …

Published: Sept. 16, 2025, midnight
Endometrial Carcinosarcoma in a Young Female with Absence of Established Risk Factors: A Case Report - Frontiers

Endometrial Carcinosarcoma in a Young Female with Absence of Established Risk Factors: A Case Report Frontiers

Published: Sept. 15, 2025, 5:41 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!